Tango Therapeutics TNGX Common Stock Shares Outstanding
Common Stock Shares Outstanding at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's common stock shares outstanding.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's common stock shares outstanding?
- Tango Therapeutics (TNGX) reported common stock shares outstanding of $313.61M in Q1 2026.
- What is the long-term trend for Tango Therapeutics's common stock shares outstanding?
- Over 5 years (2020 to 2025), Tango Therapeutics's common stock shares outstanding has grown at a -60.9% compound annual growth rate (CAGR), from $6.63B to $60.72M.
- What does common stock shares outstanding mean?
- This represents the total number of common shares held by all shareholders, including institutional investors and insiders. It serves as the denominator for calculating earnings per share and is a key indicator of potential equity dilution. Changes in this figure reflect share repurchases, new issuances, or conversion of convertible securities.